• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩大根治性手术加有限化疗后IV期胆囊癌的长期生存:1例病例报告

Long-term survival of stage 4 gallbladder cancer after extended radical surgery plus limited chemotherapy: a case report.

作者信息

Huang Zhengbin, Sun Jian, Li Changsong, Chen Sheng, Jin Tian, Wu Zhengqi

机构信息

Department of General Surgery, Hanchuan People's Hospital, 1 Renmin Avenue, Hanchuan, Hubei 431600, China.

Department of Radiology, Hanchuan People's Hospital, 1 Renmin Avenue, Hanchuan, Hubei 431600, China.

出版信息

J Surg Case Rep. 2025 Jan 20;2025(1):rjaf010. doi: 10.1093/jscr/rjaf010. eCollection 2025 Jan.

DOI:10.1093/jscr/rjaf010
PMID:39834473
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11745230/
Abstract

Gallbladder cancers (GBC) are insidious, malignant, and associated with poor prognosis, with a 5-year survival rate of 5%. Long-term survival in advanced GBC is rare. Here, we report a case of a 45-year-old female who presented with intermittent right upper quadrant pain for 1 month. A gallbladder mass and two liver masses were identified on a computed tomography (CT) scan of the abdomen and pelvis with intravenous contrast, which was highly suspicious for GBC. The patient underwent extended radical surgery, and a low to moderately differentiated gallbladder adenocarcinoma was diagnosed through pathology. Postoperatively, the patient received chemotherapy with gemcitabine and cisplatin but only tolerated one cycle. The patient has been disease-free for over 7 years, representing an unusually long survival.

摘要

胆囊癌(GBC)隐匿性强、具有恶性且预后较差,5年生存率为5%。晚期GBC患者长期生存的情况罕见。在此,我们报告一例45岁女性患者,其出现右上腹间歇性疼痛1个月。在腹部和盆腔增强计算机断层扫描(CT)中发现胆囊肿物及两个肝脏肿物,高度怀疑为GBC。患者接受了扩大根治性手术,病理诊断为低至中分化胆囊腺癌。术后,患者接受了吉西他滨和顺铂化疗,但仅耐受一个周期。该患者已无病生存超过7年,生存期异常长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/198f/11745230/079ae9932324/rjaf010f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/198f/11745230/d20973813d84/rjaf010f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/198f/11745230/079ae9932324/rjaf010f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/198f/11745230/d20973813d84/rjaf010f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/198f/11745230/079ae9932324/rjaf010f2.jpg

相似文献

1
Long-term survival of stage 4 gallbladder cancer after extended radical surgery plus limited chemotherapy: a case report.扩大根治性手术加有限化疗后IV期胆囊癌的长期生存:1例病例报告
J Surg Case Rep. 2025 Jan 20;2025(1):rjaf010. doi: 10.1093/jscr/rjaf010. eCollection 2025 Jan.
2
Long-term survival after multidisciplinary therapy for residual gallbladder cancer with peritoneal dissemination: a case report.多学科治疗残余胆囊癌伴腹膜播散后的长期生存:一例报告
Surg Case Rep. 2017 Dec;3(1):76. doi: 10.1186/s40792-017-0351-x. Epub 2017 Jun 14.
3
Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) - a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)- the AIO/ CALGP/ ACO- GAIN-trial.新辅助化疗联合吉西他滨和顺铂后根治性肝切除术与单纯胆囊切除术后或根治性 BTC 切除术前单纯根治性肝切除术或辅助化疗与或不辅助化疗在偶然发现的胆囊癌中的比较(ICC/ECC) - 德国偶然发现的胆囊癌平台(GR)登记处的 III 期研究- AIO/CALGP/ACO-GAIN 试验。
BMC Cancer. 2020 Feb 14;20(1):122. doi: 10.1186/s12885-020-6610-4.
4
Long-Term Response to Gemcitabine, Cisplatin, and Nab-Paclitaxel Followed by Maintenance Therapy for Advanced Gallbladder Cancer: A Case Report and Literature Review.吉西他滨、顺铂和纳米白蛋白结合型紫杉醇序贯维持治疗晚期胆囊癌的长期疗效:病例报告及文献综述
Front Oncol. 2021 Oct 5;11:733955. doi: 10.3389/fonc.2021.733955. eCollection 2021.
5
Impact of Retroperitoneal Lymphadenopathy (RPLN) on the Outcomes of Locally Advanced Gall Bladder Cancer (GBC) Following Chemotherapy (CT) or Chemotherapy Followed by Consolidation Chemoradiotherapy (CTRT).腹膜后淋巴结转移(RPLN)对化疗(CT)或化疗后巩固放化疗(CTRT)后局部晚期胆囊癌(GBC)结局的影响。
J Gastrointest Cancer. 2024 Oct 19;56(1):7. doi: 10.1007/s12029-024-01124-5.
6
Managing the incidentally detected gallbladder cancer: algorithms and controversies.偶然发现的胆囊癌的处理:算法和争议。
Int J Surg. 2014;12 Suppl 2:S108-S119. doi: 10.1016/j.ijsu.2014.08.367. Epub 2014 Aug 23.
7
Incidental gallbladder cancer during laparoscopic cholecystectomy: managing an unexpected finding.腹腔镜胆囊切除术中偶然发现的胆囊癌:处理意外发现。
World J Gastroenterol. 2012 Aug 14;18(30):4019-27. doi: 10.3748/wjg.v18.i30.4019.
8
Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin.吉西他滨联合顺铂治疗不可切除的胆囊癌的疗效和预后因素。
BMC Cancer. 2019 Jan 5;19(1):10. doi: 10.1186/s12885-018-5211-y.
9
Locally advanced gallbladder cancer treated with effective chemotherapy and subsequent curative resection: a case report.局部晚期胆囊癌经有效化疗和随后的根治性切除治疗:1 例报告。
J Med Case Rep. 2022 Jan 17;16(1):30. doi: 10.1186/s13256-021-03248-9.
10
A Single-Center Analysis of Patient Characteristics and Overall Survival in Patients with Resectable Gallbladder Cancer.可切除胆囊癌患者的患者特征及总生存的单中心分析
Healthcare (Basel). 2024 Oct 21;12(20):2091. doi: 10.3390/healthcare12202091.

本文引用的文献

1
Robotic, laparoscopic and open surgery for gallbladder cancer: a systematic review and network meta-analysis.机器人、腹腔镜和开放手术治疗胆囊癌:系统评价和网络荟萃分析。
Surg Endosc. 2024 Sep;38(9):4846-4857. doi: 10.1007/s00464-024-11162-6. Epub 2024 Aug 15.
2
Clinical outcomes and risk stratification in unresectable biliary tract cancers undergoing radiation therapy.不可切除胆道癌患者接受放射治疗的临床结果和风险分层。
Radiat Oncol. 2024 Aug 1;19(1):102. doi: 10.1186/s13014-024-02481-y.
3
Advances in immunotherapy for biliary tract cancers.
胆管癌免疫治疗的进展
Chin Med J (Engl). 2024 Mar 5;137(5):524-532. doi: 10.1097/CM9.0000000000002759. Epub 2023 Aug 29.
4
A Practical Guide for the Systemic Treatment of Biliary Tract Cancer in Canada.加拿大胆道癌系统治疗实用指南。
Curr Oncol. 2023 Jul 25;30(8):7132-7150. doi: 10.3390/curroncol30080517.
5
Wedge resection versus segment IVb and V resection of the liver for T2 gallbladder cancer: a systematic review and meta-analysis.T2期胆囊癌肝楔形切除术与肝IVb段和V段切除术的系统评价与Meta分析
Front Oncol. 2023 Jul 4;13:1186378. doi: 10.3389/fonc.2023.1186378. eCollection 2023.
6
Assessment of tumor markers CA 19-9, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer.评估肿瘤标志物CA 19 - 9、癌胚抗原(CEA)、CA 125和CA 242在胆囊癌早期诊断及预后预测中的作用。
World J Gastrointest Surg. 2022 Nov 27;14(11):1272-1284. doi: 10.4240/wjgs.v14.i11.1272.
7
Long-term survival of a patient with recurrent gallbladder carcinoma, treated with chemotherapy, immunotherapy, and surgery: a case report.一名复发性胆囊癌患者经化疗、免疫治疗及手术治疗后的长期生存:病例报告
Surg Case Rep. 2018 Sep 15;4(1):115. doi: 10.1186/s40792-018-0512-6.
8
Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges.肝内和肝门部胆管癌的影像学诊断:最新进展与挑战。
Radiology. 2018 Jul;288(1):7-13. doi: 10.1148/radiol.2018171187. Epub 2018 Jun 5.
9
Long-term survival after multidisciplinary therapy for residual gallbladder cancer with peritoneal dissemination: a case report.多学科治疗残余胆囊癌伴腹膜播散后的长期生存:一例报告
Surg Case Rep. 2017 Dec;3(1):76. doi: 10.1186/s40792-017-0351-x. Epub 2017 Jun 14.
10
Long-term survival of a recurrent gallbladder carcinoma patient with lymph node and peritoneal metastases after multidisciplinary treatments: a case report.一名胆囊癌复发伴淋巴结及腹膜转移患者经多学科治疗后的长期生存:病例报告
Surg Case Rep. 2016 Dec;2(1):12. doi: 10.1186/s40792-016-0135-8. Epub 2016 Feb 11.